期刊文献+

5-羟色胺受体与抑郁症相关性的研究进展 被引量:13

Research Progress in Correlation between 5-HT Receptors and Depressive Disorder
下载PDF
导出
摘要 单胺类神经递质受体学说是抑郁症发病的核心学说之一。为深入探讨5-羟色胺受体(5-HTR)与抑郁症发病机制的密切联系,该文通过检索近年国内外相关文献,回顾动物实验和临床试验等方面的相关研究,着重从5-HTR过度表达及其对神经发生的影响、单胺类神经递质抑制等方面揭示5-HTR对抑郁症发病的影响,有利于进一步归类研究5-HTR及其与抑郁症相关性和新型抗抑郁药物的研发。 Monoamine neurotransmitter receptors doctrine is one of the core theories of depression. In order to discuss the close correlation between 5-HT receptor (5-HTR) and the pathogcnesis of depression, through retrieval of related domestic and foreign literature in recent years and review of the animal experi- ments and clinical trials, here reveals the influence of 5-HTR on the pathogenesis of depression emphatically from the 5-HTR excessive expression and its influence on neurogenesis, monoamine neurotransmitter suppres- sion and so on, which is helpful to classified study of 5-HTR and its correlation with depression and the research and development of new type of antidepressant drugs.
出处 《医学综述》 2014年第5期772-775,共4页 Medical Recapitulate
基金 国家自然科学基金(81072801) 北京市自然科学基金(7093129) 北京市中医管理局项目(JJ2011-84)
关键词 5-羟色胺受体 抑郁症 发病机制 5-HT receptor Depression Pathogenesis
  • 相关文献

参考文献44

  • 1Lee S,Tsang A,Huang YQ,et al.The epidemiology of depression in metropolitan China[J] .Psychol Med,2009,39(5):735-747.
  • 2Castren E.Is mood chemistry?[J] .Nat Rev Neurosci,2005,6(3):241-246.
  • 3Berton O,Nestler EJ.New approaches to antidepressant drug discovery:beyond monoamines[J] .Nat Rev Neurosci,2006,7(2):137-151.
  • 4Wong ML,Licinio J.From monoamines to genomic targets:a paradigm shift for drug discovery in depression[J] .Nat Rev Drug Discov,2004,3(2):136-151.
  • 5Yatham LN,Liddle PF,Shiah IS,et al.Brain serotonin 2 receptors in major depression:a positron emission tomography study[J] .Arch Gen Psychiatry,2000(57):850-859.
  • 6Nordquist N,Oreland L.Serotonin,genetic variability,behaviour,and psychiatric disorders-a review[J] .Ups J Med Sci,2010,115(1):2-10.
  • 7Jlie G.Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration[J] .Life Sciences,2003,72(15):1665-1672.
  • 8Schloss P,Henn FA.New insights into the mechanisms of antidepressant therapy[J] .Pharmacol Ther,2004,102(1):47-60.
  • 9Appelberg BG,Syvalahti EK,Koskinen TE,et al.Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors:results from a placebo-controlled,randomized,double-blind,placebo wash-in study[J] .J Clin Psychiatry,2001,62(6):448-452.
  • 10Benedetti F,Radaelli D,Poletti S,et al.Association of the C(-1019)G 5-HT1A promoter polymorphism with exposure to stressors preceding hospitalization for bipolar depression[J] .J Affect Disord,2011,132(1/2):297-300.

二级参考文献123

共引文献63

同被引文献200

引证文献13

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部